Moreover, although immunization with full-length tau protein has been shown to induce histopathologic features of Alzheimer disease and tauopathies26, active or passive immunization targeting certain tau fragments or pathological tau epitopes has shown some benefit against tauopathy without adverse effects, with some in early clinical trials27, 28. The gene discussed is MAPT; the disease is Alzheimer disease.